Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
about
Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies.Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.
P2860
Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
@en
type
label
Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
@en
prefLabel
Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
@en
P2860
P356
P1476
Evidence-based practice use of incretin-based therapy in the natural history of diabetes.
@en
P2093
Stanley Schwartz
P2860
P356
10.3810/PGM.2014.05.2757
P407
P577
2014-05-01T00:00:00Z